SetBone Medical’s patent-pending cement does not have any toxic monomers and is designed to be ready for use out of the box, according to a Jan. 26 news release. Its first application is expected to be for vertebral compression fractures caused by osteoporosis.
Investors in this round include the Trendlines Group and Chicago ArchAngels.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
